Latest Diabetes: Type II news
ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
posted April 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk
posted March 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
posted March 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors
posted March 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Early Complications Common in Older Kidney Transplant Recipients .jpeg)
1997 to 2022 Saw Increase in Pediatric Hospitalizations With AKI Related Articles
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD Monthly Specialist Briefings
Stay Connected
